Changes in Hong Kong stocks | Taimei Medical Technology (02576) fell by more than 11% on the 5th of listing, the stock price was close to losing money, and the company lost more than 1.2 billion yuan in three years

The Zhitong Finance App learned that Taimei Medical Technology (02576) fell by more than 11%. Since the stock was listed on October 8, it has been declining for 5 trading days. The current stock price is close to the bottom compared to the offering price of HK$13. As of press release, it decreased by 11.23% to HK$6.64, with a turnover of HK$5.5764 million.

According to reports, Taimei Medical Technology is a digital solution provider focusing on the pharmaceutical and medical device industry in China. It designs and provides industry-specific software and digital services to help research and marketing of pharmaceuticals and medical devices. According to Insight Consulting, in terms of revenue in 2023, Taimei Medical Technology is the largest digital solution provider in the field of pharmaceutical and medical device R&D and marketing in China, with a market share of 5.9%.

According to financial data, from 2021 to 2023, the company's revenue was 466 million yuan, 549 million yuan, and 573 million yuan, respectively. Despite a steady increase in revenue, losses continued during the period. In the first quarter of this year, Taimei Medical's revenue was 132 million yuan, and the net loss was 118 million yuan. The cumulative loss over three years has exceeded 1.2 billion yuan.